Advanced search
Publication Cover
Expert Review of Hematology Volume 16, 2023 - Issue 12
Submit an article Journal homepage
3,785
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Dual target dilemma: navigating epcoritamab vs. glofitamab in relapsed refractory diffuse large B-cell lymphoma

James A. Davisa Department of Malignant Hematology and Bone Marrow Transplant, The Medical University of South Carolina Hollings Cancer Center, Charleston, SC, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7978-1652View further author information
ORCID Icon,
Katelynn Grangera Department of Malignant Hematology and Bone Marrow Transplant, The Medical University of South Carolina Hollings Cancer Center, Charleston, SC, USAView further author information
,
Alex Sakowskia Department of Malignant Hematology and Bone Marrow Transplant, The Medical University of South Carolina Hollings Cancer Center, Charleston, SC, USAView further author information
,
Sara Goodwina Department of Malignant Hematology and Bone Marrow Transplant, The Medical University of South Carolina Hollings Cancer Center, Charleston, SC, USAView further author information
,
Amanda Herbsta Department of Malignant Hematology and Bone Marrow Transplant, The Medical University of South Carolina Hollings Cancer Center, Charleston, SC, USAView further author information
,
Deidra Smitha Department of Malignant Hematology and Bone Marrow Transplant, The Medical University of South Carolina Hollings Cancer Center, Charleston, SC, USAView further author information
,
Lindsey Hendricksona Department of Malignant Hematology and Bone Marrow Transplant, The Medical University of South Carolina Hollings Cancer Center, Charleston, SC, USAView further author information
&
Victoria R. Nacharb Department of Pharmacy, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USAView further author information
 show all
Pages 915-918 | Received 04 Oct 2023, Accepted 16 Nov 2023, Published online: 20 Nov 2023
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Declaration of interest

V Nachar has received advisory fees from Genmab and Genentech. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reviewer disclosures

A peer reviewer on this manuscript has received consultancy fees or honoraria from AbbVie, Roche, Novartis, Kyte/Gilead, Incyte, and Amgen. One peer reviewer is a consultant for both AbbVie and Roche. Peer reviewers on this manuscript have no other relevant financial relationships or otherwise to disclose.

Additional information

Funding

This paper was not funded.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Download PDF

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.